Glycogen Synthase Kinase 3beta Is a Natural Activator of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase Kinase 1 (MEKK1)*

Jin Woo KimDagger , Ji Eun LeeDagger , Myung Jin KimDagger , Eun-Gyung ChoDagger §, Ssang-Goo ChoDagger , and Eui-Ju ChoiDagger ||

From the Dagger  National Creative Research Initiative Center for Cell Death, Graduate School of Life Science and Biotechnology, Korea University, Seoul 136-701, Korea and  Department of Animal Science, Konkuk University, Seoul 143-702, Korea

Received for publication, January 9, 2003, and in revised form, February 10, 2003

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Glycogen synthase kinase 3beta (GSK3beta ) is implicated in many biological events, including embryonic development, cell differentiation, apoptosis, and insulin response. GSK3beta has now been shown to induce activation of the mitogen-activated protein kinase kinase kinase MEKK1 and thereby to promote signaling by the stress-activated protein kinase pathway. GSK3beta -binding protein blocked the activation of MEKK1 by GSK3beta in human embryonic kidney 293 (HEK293) cells. Furthermore, co-immunoprecipitation analysis revealed a physical association between endogenous GSK3beta and MEKK1 in HEK293 cells. Overexpression of axin1, a GSK3beta -regulated scaffolding protein, did not affect the physical interaction between GSK3beta and MEKK1 in transfected HEK293 cells. Exposure of cells to insulin inhibited the activation of MEKK1 by GSK3beta , and this inhibitory effect of insulin was abolished by the phosphatidylinositol 3-kinase inhibitor wortmannin. Furthermore, MEKK1 activity under either basal or UV- or tumor necrosis factor alpha -stimulated conditions was reduced in embryonic fibroblasts derived from GSK3beta knockout mice compared with that in such cells from wild-type mice. Ectopic expression of GSK3beta increased both basal and tumor necrosis factor alpha -stimulated activities of MEKK1 in GSK3beta -/- cells. Together, these observations suggest that GSK3beta functions as a natural activator of MEKK1.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Glycogen synthase kinase 3beta (GSK3beta )1 is a serine/threonine kinase that is thought to contribute to a variety of biological events such as embryonic development, metabolism, tumorigenesis, and cell death (1-4). GSK3beta is a constitutively active kinase and regulates many intracellular signaling pathways by phosphorylating substrates such as beta -catenin. The phosphorylation of beta -catenin by GSK3beta is facilitated by the scaffold protein axin and is inhibited either by GSK3beta -binding protein (GBP), also known as Frat (Frequently rearranged in advanced T-cell lymphomas), or by Dishevelled (5-7). The GSK3beta -catalyzed phosphorylation of beta -catenin results in its ubiquitin-mediated proteolysis (8, 9). The function of GSK3beta is also regulated through phosphorylation by other protein kinases including Akt (10-13). Akt is a serine/threonine kinase that is activated by phosphatidylinositol 3-kinase (PI3K) signaling and phosphorylates GSK3beta on Ser9, thereby inactivating it (10, 14, 15).

Mitogen-activated protein kinase (MAPK) signaling cascades are evolutionarily conserved from yeast to humans and are involved in a variety of cellular functions, including cell growth, differentiation, and cell death (16-19). Each MAPK signaling pathway includes three components, a MAPK, a MAPK kinase, and a MAPK kinase kinase. An activated MAPK kinase kinase phosphorylates serine or threonine residues of a MAPK kinase, which in turn phosphorylates and thereby activates a MAPK (16-18). The mammalian family of MAPKs includes at least three subgroups, extracellular signal-regulated kinases, c-Jun NH2-terminal kinases (JNKs), also known as stress-activated protein kinases (SAPKs), and p38 MAPK (17, 18). The extracellular signal-regulated kinase pathway is activated by various mitogens (19), whereas the JNK/SAPK and p38 pathways are activated by proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha ) as well as cellular stresses (16-18). The JNK/SAPK pathway, which is associated with stress-induced cellular events including cell death (20-27), is composed of JNK/SAPK, a MAPK kinase such as MKK4 (also known as SEK1 or JNKK1) and MKK7, and a MAPK kinase kinase such as MEKK1 (16-18).

To provide further insight into the regulatory role of GSK3beta in intracellular signaling cascades, we have now investigated the effect of this enzyme on the JNK/SAPK pathway. We show that GSK3beta physically associates with and activates MEKK1, thereby stimulating the JNK/SAPK pathway. The PI3K-Akt signaling inhibited the GSK3beta -induced activation of MEKK1. Furthermore, the activity of endogenous MEKK1 was reduced in mouse embryonic fibroblasts (MEFs) derived from GSK3beta knockout (GSK3beta -/-) mice compared with that in MEFs from GSK3beta +/+ mice. These findings suggest that GSK3beta functions as an endogenous activator of MEKK1.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Antibodies-- Mouse monoclonal antibodies to GSK3beta and to axin as well as rabbit polyclonal antibodies against MEKK1 and apoptosis signal-regulating kinase 1 (ASK1) were purchased from Santa Cruz Biotechnology. Mouse monoclonal antibody to JNK1 was from BD Pharmingen. Mouse monoclonal antibodies to the hemagglutinin epitope (HA) and to the FLAG epitope were obtained from Roche Molecular Biochemicals and Stratagene, respectively.

Plasmid Constructs-- MEKK1 constructs used were prepared as described previously (28). GSK3beta , GSK3beta (K85A), and GSK3beta (S9A) cDNAs were isolated by the polymerase chain reaction using primers (5'-GCGGAATTCATGTCAGGGCGGCCCAGA-3' and 5'-CGCCTCGAGGGTGGAGTTGGAAGCTGATGC-3') and cloned into pCMV5-FLAG (Eastman Kodak Co.). cDNAs for GSK3beta deletion mutants (NT, CEN, Delta N, and Delta C) were made by the polymerase chain reaction and cloned into the EcoRI/XhoI sites of pcDNA3-HA (Invitrogen).

Cell Culture and Transfection-- Human embryonic kidney 293 (HEK293) and rat neuroblastoma B103 cells were maintained under a humidified atmosphere of 5% CO2 at 37 °C in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum and 100 units/ml penicillin/streptomycin (Invitrogen). Cells were transiently transfected with the use of GenePORTER II (Gene Therapy Systems), by the calcium phosphate method, or by electroporation.

Apoptotic Cell Death-- B103 cells were transfected for 48 h with pEGFP (Clontech) and the appropriate vector constructs, fixed with 4% paraformaldehyde, and then stained with 4',6-diamidino-2-phenylindole (10 µg/ml) for 10 min. The 4',6-diamidino-2-phenylindole-stained nuclei of cells expressing green fluorescence protein (GFP) were examined for apoptotic morphology with a Zeiss Axiovert fluorescence microscope. The percentage of apoptotic cell death was determined as the number of GFP-expressing cells with apoptotic nuclei divided by the total number of GFP-expressing cells. More than 200 cells were counted in each experiment.

Co-immunoprecipitation-- Cells were lysed in buffer A consisting of 20 mM Tris-HCl (pH 7.4), 150 mM sodium chloride, 1% Triton X-100, 1% deoxycholate, 12 mM beta -glycerophosphate, 10 mM sodium fluoride, 5 mM EGTA, and 1 mM phenylmethylsulfonyl fluoride. Cell lysates were subjected to centrifugation at 12,000 × g for 15 min at 4 °C, and the resulting supernatants were subjected to immunoprecipitation with the appropriate antibodies. The resulting precipitates were washed four times with buffer A and then examined by SDS-PAGE and immunoblot analysis.

Immunocomplex Kinase Assays-- Cells were lysed in buffer A, and the cell lysates were subjected to immunoprecipitation as described above. The resulting immunoprecipitates were assayed for enzymatic activities of the indicated protein kinases as described previously (29, 30). Phosphorylated proteins were separated by SDS-PAGE, and the extent of phosphorylation was quantified with a Fuji BAS2500 imager. Bacterially expressed glutathione S-transferase (GST) fusion proteins of c-Jun-(1-79), SAPKbeta (K55R), SEK1(K129R), and beta -catenin were used as substrates for JNK/SAPK, SEK1, MEKK1, and GSK3beta , respectively.

In Vitro Binding Analysis-- GSK3beta and its variants were translated in vitro in the presence of [35S]methionine with the use of a rabbit reticulocyte lysate system (Promega). The resulting 35S-labeled GSK3beta proteins were then incubated for 3 h at 4 °C with bacterially expressed GST fusion proteins of MEKK1 variants in a solution containing 50 mM Tris, pH 7.5, 150 mM NaCl, 2 mM EDTA, 1 mM dithiothreitol, 0.1% Nonidet P-40, and 5 mg/ml bovine serum albumin. The GST fusion proteins were recovered with the use of glutathione-agarose beads. The beads were then washed three times with washing buffer (50 mM Hepes, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 0.1% Tween 20). The associated 35S-labeled proteins were eluted from the beads and analyzed by SDS-PAGE and autoradiography.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

GSK3beta Induces the Activation of MEKK1-- To investigate the possible effect of GSK3beta on the SAPK/JNK signaling pathway, we first transfected HEK293 cells with plasmid encoding HA-tagged SAPKbeta either alone or together with a vector for FLAG epitope-tagged GSK3beta or GSK3beta (K85A). Exposure of the transfected cells to UV resulted in activation of the recombinant SAPKbeta (Fig. 1A). This effect of UV irradiation was enhanced by ectopic expression of GSK3beta but not by that of the mutant GSK3beta (K85A), which is catalytically inactive (31). Rather, GSK3beta (K85A) inhibited the UV-induced activation of SAPKbeta . Whereas overexpressed GSK3beta also increased the basal activity of SAPKbeta , it did not enhance either the basal activity or the phorbol 12-myristate 13-acetate-stimulated activity of extracellular signal-regulated kinase 2 (Fig. 1A).


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 1.   GSK3beta induces the stimulation of MEKK1, SEK1, and JNK. A, HEK293 cells were transfected for 48 h with expression vectors encoding HA-SAPKbeta (left panel) or HA-extracellular signal-regulated kinase (HA-ERK2) (right panel) either alone or together with vectors for FLAG-GSK3beta or FLAG-GSK3beta (K85A) as indicated. The cells were then either unexposed or exposed to UV light (80 J/m2) (left panel) or 200 nM phorbol 12-myristate 13-acetate (right panel). After 30 min, cell lysates were subjected to immunoprecipitation with mouse monoclonal anti-HA antibody. The resulting immunoprecipitates were examined for SAPKbeta activity (left panel) or extracellular signal-regulated kinase 2 activity (right panel) by immunocomplex kinase assays with GST-c-Jun-(1-79) or myelin basic protein (MBP), respectively, as substrates. The fold increase in activity relative to that of control cells is indicated. Cell lysates were also subjected to immunoblot analysis (IB) with antibodies to HA or to FLAG. Graphs in the bottom show the means ± average deviation of three independent experiments. B and C, HEK293 cells were transfected for 48 h with a vector encoding GST-SEK1 (B) or HA-MEKK1 (C) either alone or together with a vector for GSK3beta -FLAG or GSK3beta (K85A)-FLAG, as indicated. The cells were then untreated or treated with UV light (80 J/m2) and further incubated for 30 min. In B, GST-SEK1 expressed in the transfected cells was isolated from cell lysates with the use of glutathione-agarose beads and then assayed for kinase activity with GST-SAPKbeta (K55R) as substrate. In C, cell lysates were subjected to immunoprecipitation with antibody to HA, and the resulting precipitates were assayed for MEKK1 activity with GST-SEK1(K129R) as substrate. Graphs in the bottom show the means ± average deviation for SEK1 and MEKK1 activity, respectively, of three independent experiments. D, HEK293 cells were transfected for 48 h with an expression vector encoding GST-JNK1 either alone or together with the indicated combinations of vectors for GSK3beta -FLAG, HA-MEKK1, HA-MEKK1(K1253M), HA-ASK1, or HA-ASK1(K709R). The cells were then unexposed or exposed to UV light (80 J/m2) and incubated for an additional 30 min. GST-JNK1 was precipitated from cell lysates with glutathione-agarose beads and assayed for kinase activity with GST-c-Jun-(1-79) as substrate.

We next examined whether GSK3beta affects the activities of SEK1 and MEKK1, which function as MAPK kinase and MAPK kinase kinase of JNK/SAPK, respectively. Overexpressed GSK3beta increased in both the basal and UV-stimulated activities of SEK1 and MEKK1 (Fig. 1, B and C). In contrast, GSK3beta did not increase the activity of ASK1 (data not shown), which also functions as a MAPK kinase kinase of JNK/SAPK (32). Furthermore, the GSK3beta -induced activation of JNK1/SAPKgamma was inhibited by expression of MEKK1(K1253M) (Fig. 1D), a catalytically inactive mutant of MEKK1, but not by ASK1(K709R), a kinase-inactive mutant of ASK1. Collectively, these results suggest that GSK3beta induces the activation of MEKK1, thereby triggering JNK/SAPK activation.

We then examined the possible effect of GBP, an intracellular inhibitor of GSK3beta (7), on the activation of MEKK1 by GSK3beta . Overexpressed GBP inhibited the GSK3beta -induced increase in MEKK1 activity (Fig. 2A). Furthermore, exposure of HEK293 cells to LiCl, which functions as an inhibitor of GSK3beta (33, 34), resulted in a concentration-dependent reduction in the activities of endogenous JNK1 and MEKK1 (Fig. 2B).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of GBP and LiCl on the JNK/SAPK signaling pathway. A, HEK293 cells were transfected for 48 h with plasmid encoding HA-MEKK1 either alone or together with plasmids for GSK3beta -FLAG and GBP as indicated. Cell lysates were then subjected to immunoprecipitation with anti-HA antibody, and the resulting precipitates were assayed for MEKK1 activity with GST-SEK1(K129R) as substrate. Cells were also subjected to immunoblot analysis with antibodies to HA or to FLAG. B, HEK293 cells were treated for 30 min with LiCl at the indicated concentrations. Cell lysates were then subjected to immunoprecipitation with antibodies to JNK1 or to MEKK1. The resulting immunoprecipitates were assayed for JNK1 or MEKK1 activity with GST-c-Jun-(1-79) or GST-SEK1(K129R), respectively, as substrates. IB, immunoblot.

GSK3beta Induces MEKK1 Activation in an Axin-independent Manner-- Axin, a GSK3beta -regulated scaffolding protein (4), has been shown to activate MEKK1 through a direct protein-protein interaction (35, 36). Furthermore, axin interacts with both GSK3beta and MEKK1, implying that it might function as a molecular linker for MEKK1 and GSK3beta (36). We therefore examined whether axin mediates the GSK3beta -induced activation of MEKK1. HEK293 cells were cotransfected with an HA-MEKK1 vector and various combinations of GSK3beta -FLAG, axin1, and axin1Delta -(217-353) constructs, and then cell lysates were examined for MEKK1 activity. Axin1Delta -(217-353), which lacks the MEKK1-interacting domain, exerts a dominant-negative effect on axin-induced MEKK1 activation (36). Overexpression of either GSK3beta or axin1 induced MEKK1 activation in HEK293 cells, and these effects of GSK3beta and axin1 were additive (Fig. 3). Whereas axin1Delta -(217-353) inhibited the activation of MEKK1 by axin1, it did not affect that induced by GSK3beta . These data suggest that GSK3beta induces MEKK1 activation in an axin-independent manner.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 3.   Axin1Delta -(217-353) does not inhibit GSK3beta -induced activation of MEKK1. HEK293 cells were transfected for 48 h with an expression vector encoding HA-MEKK1 and the indicated combinations of vectors for GSK3beta -FLAG, axin1, and axin1Delta -(217-353). Cell lysates were then subjected to immunoprecipitation with anti-HA antibody, and the resulting immunoprecipitates were assayed for MEKK1 activity with GST-SEK1(K129R) as substrate. Cell lysates were also subjected to immunoblot (IB) analysis with anti-HA or anti-FLAG antibody to show expression of HA-MEKK1, HA-axin1, HA-axin1Delta -(217-353), or GSK3beta -FLAG.

GSK3beta Physically Associates with MEKK1-- We next investigated whether GSK3beta interacts with MEKK1 in intact cells. HEK293 cells were transfected with a GSK3beta -FLAG vector either alone or together with vectors for HA-MEKK1 or HA-axin1. Co-immunoprecipitation analysis revealed the presence of HA-MEKK1 in GSK3beta -FLAG immunoprecipitates (Fig. 4A). HA-axin1 also associated with GSK3beta -FLAG, but it did not affect the extent of the physical interaction between GSK3beta -FLAG and HA-MEKK1. Similar analysis of non-transfected cells with antibodies to GSK3beta and to MEKK1 also revealed an interaction of the two endogenous proteins (Fig. 4B). This interaction was not markedly affected by exposure of the cells to UV radiation. In comparison, endogenous GSK3beta did not interact with endogenous ASK1.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   GSK3beta physically associates with MEKK1 in intact cells. A, interaction of ectopic GSK3beta and MEKK1 in transfected HEK293 cells. Cells were transfected for 48 h with an expression vector encoding GSK3beta -FLAG either alone or together with vectors for HA-MEKK1 or HA-axin1, as indicated. Cell lysates were then subjected to immunoprecipitation (IP) with anti-FLAG antibody, and the resulting precipitates were examined by immunoblot analysis with anti-HA antibody. Cell lysates were also subjected to immunoblot analysis with anti-HA or anti-FLAG antibody. B, physical interaction between endogenous GSK3beta and MEKK1 in HEK293 cells. Cells were unexposed or exposed to UV (80 J/m2) and then incubated for 15 min before immunoprecipitation with either mouse preimmune IgG or anti-GSK3beta antibody. The resulting immunoprecipitates were subjected to immunoblot analysis with anti-MEKK1 or anti-ASK1 antibody. IgGH, the heavy chain of immunoglobulin G.

Next, we examined whether GSK3beta interacts directly with MEKK1 in vitro. In vitro translated 35S-labeled GSK3beta was incubated with GST-MEKK1 fusion proteins, and an interaction between the two proteins was examined by GST pull-down analysis. 35S-Labeled GSK3beta bound to MEKK1-N1 (amino acids 1-401 of MEKK1) and MEKK1-N2 (amino acids 402-821) but not to MEKK1-Delta NC (amino acids 822-1172) or Delta MEKK1 (amino acids 1173-1493) (Fig. 5A). The Delta MEKK1 mutant is a constitutively active form of MEKK1. In a separate in vitro binding analysis with GST-MEKK1-N1 and 35S-labeled GSK3beta variants, MEKK1-N1 bound to full-length GSK3beta , GSK3beta -NT (amino acids 1-150), and GSK3beta -Delta C (amino acids 1-300), but not to GSK3beta -CEN (amino acids 151-300) or GSK3beta -Delta N (amino acids 151-420) (Fig. 5B). These results thus suggest that the NH2-terminal region that contains amino acids 1-150 of GSK3beta is required for binding to MEKK1. Neither GST-MEKK1-Delta NC nor GST-Delta MEKK1 interacted with the various GSK3beta deletion mutants (data not shown). GSK3beta phosphorylated both MEKK1 and the kinase-inactive mutant MEKK1(K1253M) in vitro, and these phosphorylation reactions were inhibited by LiCl (Fig. 5C). LiCl also inhibited the autophosphorylation of GSK3b.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 5.   Direct interaction between GSK3beta and MEKK1 in vitro. A, 35S-labeled GSK3beta was produced by in vitro translation and incubated for 3 h at 4 °C with GST alone or the indicated GST-fused deletion mutants of MEKK1. The GST fusion proteins were recovered with the use of glutathione-agarose beads, and the bead-bound proteins were eluted and analyzed by SDS-PAGE and autoradiography. B, in vitro translated 35S-labeled GSK3beta variants were incubated for 3 h at 4 °C with GST or GST-MEKK1-N1, after which the 35S-labeled GSK3beta variants associated with GST-MEKK1-N1 were detected as in A. C, phosphorylation of MEKK1 by GSK3beta in vitro. HEK293 cells were transfected for 48 h with plasmids encoding GSK3beta -FLAG, HA-MEKK1, or HA-MEKK1(K1253M). Cell lysates were then subjected to immunoprecipitation with anti-FLAG or anti-HA antibody. In vitro phosphorylation assays were performed for 30 min at 30 °C with the indicated combinations of HA-MEKK1, HA-MEKK1(K1253M), and GSK3beta -FLAG immunoprecipitates and 10 mM LiCl in the presence of [gamma -32P]ATP (100 µCi/ml). Phosphorylated proteins were analyzed by SDS-PAGE and autoradiography.

Akt Inhibits GSK3beta -induced MEKK1 Activation-- Akt phosphorylates GSK3beta on Ser9 and thereby inactivates this enzyme (4, 10, 15). We therefore examined whether Akt negatively regulates the activation of MEKK1 by GSK3beta . HEK293 cells were transfected with an HA-MEKK1 vector either alone or together with various combinations of vectors for GSK3beta -FLAG, GSK3beta (S9A)-FLAG, Akt-CA, and Akt(K179A). Akt-CA is a myristoylated form of Akt that is constitutively active (37), and Akt(K179A) is a kinase-inactive mutant of Akt. Ectopic GSK3beta induced MEKK1 activation in the transfected cells, and this activation was inhibited by Akt-CA but not by Akt(K179A) (Fig. 6A). In contrast, Akt-CA failed to inhibit MEKK1 activation induced by GSK3beta (S9A), which is resistant to the Akt-mediated phosphorylation as a result of the substitution of Ser9 with Ala.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 6.   PI3K and Akt inhibit GSK3beta -induced activation of MEKK1. A, HEK293 cells were transfected for 48 h with a vector encoding HA-MEKK1 and the indicated combinations of vectors for GSK3beta -FLAG, GSK3beta (S9A)-FLAG, Akt-CA, and Akt(K129R). Cell lysates were then subjected to immunoprecipitation with anti-HA antibody, and the resulting immunoprecipitates were assayed for MEKK1 activity with GST-SEK1(K129R) as substrate. Cell lysates were also subjected to immunoblot (IB) analysis with antibodies to HA and to FLAG. B, HEK293 cells were transfected for 48 h with a vector encoding HA-MEKK1 either alone or together with a vector for GSK3beta -FLAG. The cells were incubated in the absence or presence of 200 nM wortmannin for 30 min and then without or with 1 µM insulin for 30 min. Cell lysates were then assayed for MEKK1 activity as in A.

Insulin initiates the activation of PI3K that in turn induces Akt activation (38-40). We thus investigated whether insulin is also able to block the GSK3beta -induced activation of MEKK1. The activation of MEKK1 by GSK3beta in transfected HEK293 cells was inhibited by an exposure of the cells to insulin (Fig. 6B). Furthermore, the inhibitory effect of insulin was abolished by the PI3K inhibitor wortmannin. These results suggest that the insulin-activated PI3K negatively regulates the activation of MEKK1 by GSK3beta .

The Kinase-inactive Mutant MEKK1(K1253M) Blocks GSK3beta -induced Apoptosis-- GSK3beta has been shown to induce cell death in several studies (31, 41). Persistent activation of MEKK1 also induces apoptosis (42, 43). We therefore investigated the possibility that MEKK1 activation mediates apoptosis induced by GSK3beta . Neuroblastoma B103 cells were transiently transfected with vectors encoding GSK3beta or GSK3beta (S9A) in the absence or presence of a vector for the dominant-negative mutant MEKK1(K1253M), after which the cells were examined for apoptosis (Fig. 7). Overexpressed GSK3beta or GSK3beta (S9A) increased apoptosis in the transfected cells, and co-expression of MEKK1(K1253M) inhibited this effect. These results thus suggest that activation of MEKK1 contributes to the induction of apoptosis by GSK3beta . Insulin blocked the induction of apoptosis by GSK3beta but not that by the Akt-resistant mutant GSK3beta (S9A).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7.   Role of MEKK1 activation in GSK3beta -induced apoptosis in neuroblastoma B103 cells. Cells were transfected for 24 h with pEGFP and the indicated combinations of expression vectors encoding GSK3beta , GSK3beta (S9A), and MEKK1(K1253M). The cells were then untreated or treated with 1 µM insulin for 16 h, fixed, and stained with 4',6-diamidino-2-phenylindole. GFP-expressing cells were examined for the apoptotic nuclei by fluorescence microscopy. The percentage of apoptotic cells was determined, and data are the means ± S.E. of values from the representative from two independent experiments.

Reduced MEKK1 Activity in MEFs Derived from GSK3beta Null Mice-- To confirm the biological relevance of GSK3beta -induced MEKK1 activation, we examined the basal, UV-stimulated, and TNFalpha -stimulated activities of MEKK1 in MEFs derived from GSK3beta +/+ and GSK3beta -/- mice (Fig. 8A). The MEKK1 activities under all three conditions were higher in MEFGSK3beta (+/+) than MEFGSK3beta (-/-). Furthermore, ectopic expression of GSK3beta increased both the basal and TNFalpha -stimulated activities of MEKK1 in MEFGSK3beta (-/-) (Fig. 8B). In comparison, expression of the kinase-inactive mutant GSK3beta (K85A) did not affect the basal or TNFalpha -stimulated activities of MEKK1 in MEFGSK3beta (-/-). These data thus suggest that GSK3beta functions as a natural activator of MEKK1.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 8.   MEKK1 activity is higher in MEF cells from GSK3beta (+/+) mice than in MEF cells from GSK3beta -null mice. A, MEF cells from either GSK3beta +/+ or GSK3beta -/- mice were left untreated, exposed to UV (80 J/m2), and then incubated for 30 min or treated with TNF-alpha (20 ng/ml) for 15 min. Cell lysates were then subjected to immunoprecipitation with anti-MEKK1 or anti- GSK3beta antibody. The resulting immunoprecipitates were examined for MEKK1 or GSK3beta activity by immunocomplex kinase assay. B, MEFGSK3beta (-/-) cells were transfected for 48 h with a vector encoding HA-MEKK1 either alone or together with a vector for GSK3beta -FLAG or GSK3beta (K85A)-FLAG. The cells were then incubated for 15 min in the absence or presence of TNF-alpha (20 ng/ml). Cell lysates were subjected to immunoprecipitation with anti-HA antibody, and the resulting immunoprecipitates were assayed for MEKK1 activity as in A. IB, immunoblot.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have shown that GSK3beta physically interacts with and activates MEKK1, thereby triggering the JNK/SAPK signaling pathway. Insulin-activated PI3K and Akt inhibited the GSK3beta -induced activation of MEKK1. Furthermore, MEKK1 activity was reduced in MEFs from GSK3beta -/- mice compared with that in MEFs from wild-type animals, and forced expression of GSK3beta increased MEKK1 activity in the cells from GSK3beta -/- mice. Our data thus indicate that GSK3beta is an activator of MEKK1.

Axin, a GSK3beta -interacting protein, was also recently shown to interact directly with and to activate MEKK1 (36). It implies that axin might mediate the activation of MEKK1 by GSK3beta . Our results, however, indicate that GSK3beta physically associates with and activates MEKK1 in a manner independent of axin. MEKK1 is activated as a result of phosphorylation by upstream kinases or through binding to oligomeric forms of upstream regulators such as TNF receptor associated factor 2 (44, 45). GSK3beta might thus induce the activation of MEKK1 by phosphorylation given that MEKK1 contains several potential sites for GSK3beta -catalyzed phosphorylation. Indeed, the kinase-inactive mutant GSK3beta (K85A) failed to activate MEKK1. Moreover, GSK3beta phosphorylated MEKK1 in vitro. Further studies are needed to identify a phosphorylation site(s) in MEKK1 targeted by GSK3beta . We cannot also exclude the possibility that the physical interaction between GSK3beta and MEKK1 induces the activation of MEKK1 through a mechanism independent of protein phosphorylation.

In this study we demonstrate that insulin inhibited the activation of MEKK1 by GSK3beta and that this effect of insulin was abolished by the PI3K inhibitor wortmannin. Furthermore, Akt inhibited GSK3beta -induced MEKK1 activation. These observations thus suggest that PI3K and Akt modulate the JNK/SAPK signaling pathway through inhibition of GSK3beta -induced MEKK1 activation. Many lines of evidence have previously demonstrated PI3K and Akt as negative regulators of the JNK/SAPK cascade (46-50). Akt phosphorylates and inhibits both ASK1 (47) and SEK1 (50), both of which actions result in inhibition of JNK/SAPK. Thus, PI3K and Akt appear to tightly regulate the JNK/SAPK signaling pathway by means of multiple mechanisms.

GSK3beta is implicated in many biological events, including signaling activated by Wnt and glycogen metabolism (4). GSK3beta -deficient mice, however, do not exhibit any marked alterations in the Wnt-induced embryonic development or glycogen metabolism (51). Interestingly, the activation of the transcription factor NF-kappa B by TNF-alpha is impaired in MEFs from GSK3beta -deficient mice (51). We now show that MEKK1 activity under either basal or UV- or TNF-alpha -stimulated condition is reduced in MEFs from GSK3beta -deficient mice compared with that in MEFs from wild-type mice, consistent with the notion that GSK3beta potentiates the function of MEKK1. Thus, our results demonstrate that GSK3beta is an endogenous activator of MEKK1. This function of GSK3beta may be an important aspect of the mechanism by which this enzyme modulates intracellular signaling, including that triggered by cellular stress.

    ACKNOWLEDGEMENTS

We thank Dr. J. W. Woodgett for providing wild-type and GSK3beta -/- MEFs and SAPKbeta cDNA. We also thank Dr. R. J. Davis, Dr. G. Johnson, Dr. H. Ichijo, Dr. L. I. Zon, Dr. J. Chung, Dr. S. C. Lin, and Dr. D. Kimelman for providing JNK1, MEKK1, ASK1, SEK1, Akt, axin1, and GBP cDNA vector constructs and Dr. W. A. Toscano, Jr. for critical reading of the manuscript.

    FOOTNOTES

* This work was supported by the Creative Research Initiatives Program of the Korean Ministry of Science and Technology and in part by a Korea University Grant (to E.-J. C.), and in part by the faculty research fund of Konkuk University (to S.-G. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by a postdoctoral fellowship from the BK21 program of the Korean Ministry of Education.

|| To whom correspondence should be addressed. Tel.: 82-2-3290-3446; Fax: 82-2-3290-4741; E-mail: ejchoi@korea.ac.kr.

Published, JBC Papers in Press, February 12, 2003, DOI 10.1074/jbc.M300253200

    ABBREVIATIONS

The abbreviations used are: GSK3beta , glycogen synthase kinase 3beta ; GBP, GSK3beta -binding protein; PI3K, phosphatidylinositol 3-kinase; MAPK, mitogen-activated protein kinase; JNK, c-Jun N-terminal kinase; SAPK, stress-activated protein kinase; ASK1, apoptosis signal-regulating kinase 1; HA, hemagglutinin; MEF, mouse embryonic fibroblast; GFP, green fluorescence protein; TNF-alpha , tumor necrosis factor alpha ; HEK293, human embryonic kidney 293; GST, glutathione S- transferase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Bienz, M. (1999) Curr. Opin. Genet. Dev. 9, 595-603[CrossRef][Medline] [Order article via Infotrieve]
2. Ferkey, D. M., and Kimelman, D. (2000) Dev. Biol. 225, 471-479[CrossRef][Medline] [Order article via Infotrieve]
3. Kim, L., and Kimmel, A. R. (2000) Curr. Opin. Genet. Dev. 10, 508-514[CrossRef][Medline] [Order article via Infotrieve]
4. Woodgett, J. R. (2001) Science's STKE http://www.stke.org/cgi/content/full/ OC_sigtrans;2001/100/re12
5. Fagotto, F., Jho, E., Zeng, L., Kurth, T., Joos, T., Kaufmann, C., and Costantini, F. (1999) J. Cell Biol. 145, 741-756[Abstract/Free Full Text]
6. Li, L., Yuan, H., Weaver, C. D., Mao, J., Farr, G. H., III, Sussman, D. J., Jonkers, J., Kimelman, D., and Wu, D. (1999) EMBO J. 18, 4233-4240[Abstract/Free Full Text]
7. Yost, C., Farr, G. H., III, Pierce, S. B., Ferkey, D. M., Chen, M. M., and Kimelman, D. (1998) Cell 93, 1031-1041[Medline] [Order article via Infotrieve]
8. Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B., and Polakis, P. (1998) Curr. Biol. 8, 573-581[Medline] [Order article via Infotrieve]
9. Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., and Polakis, P. (1996) Science 272, 1023-1026[Abstract]
10. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995) Nature 378, 785-789[CrossRef][Medline] [Order article via Infotrieve]
11. Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Jr., Woodgett, J. R., and Mills, G. B. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 11960-11965[Abstract/Free Full Text]
12. Hartigan, J. A., Xiong, W. C., and Johnson, G. V. (2001) Biochem. Biophys. Res. Commun. 284, 485-489[CrossRef][Medline] [Order article via Infotrieve]
13. Oriente, F., Formisano, P., Miele, C., Fiory, F., Maitan, M. A., Vigliotta, G., Trencia, A., Santopietro, S., Caruso, M., Condorelli, G., Van Obberghen, E., and Beguinot, F. (2001) J. Biol. Chem. 276, 37109-37119[Abstract/Free Full Text]
14. Hemmings, B. A. (1997) Science 275, 628-630[Free Full Text]
15. Shaw, M., Cohen, P., and Alessi, D. R. (1997) FEBS Lett. 416, 307-311[CrossRef][Medline] [Order article via Infotrieve]
16. Davis, R. J. (2000) Cell 103, 239-252[Medline] [Order article via Infotrieve]
17. Ip, Y. T., and Davis, R. J. (1998) Curr. Opin. Cell Biol. 10, 205-219[CrossRef][Medline] [Order article via Infotrieve]
18. Minden, A., and Karin, M. (1997) Biochim. Biophys. Acta 1333, 85-104
19. Schaeffer, H. J., and Weber, M. J. (1999) Mol. Cell. Biol. 19, 2435-2444[Free Full Text]
20. Chen, Y. R., Wang, X., Templeton, D., Davis, R. J., and Tan, T. H. (1996) J. Biol. Chem. 271, 31929-31936[Abstract/Free Full Text]
21. Dong, C., Yang, D. D., Wysk, M., Whitmarsh, A. J., Davis, R. J., and Flavell, R. A. (1998) Science 282, 2092-2095[Abstract/Free Full Text]
22. Kuan, C. Y., Yang, D. D., Samanta Roy, D. R., Davis, R. J., Rakic, P., and Flavell, R. A. (1999) Neuron 22, 667-676[Medline] [Order article via Infotrieve]
23. Seimiya, H., Mashima, T., Toho, M., and Tsuruo, T. (1997) J. Biol. Chem. 272, 4631-4636[Abstract/Free Full Text]
24. Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., and Davis, R. J. (2000) Science 288, 870-874[Abstract/Free Full Text]
25. Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. N. (1996) Nature 380, 75-79[CrossRef][Medline] [Order article via Infotrieve]
26. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. (1995) Science 270, 1326-1331[Abstract]
27. Zanke, B. W., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L. A., Zon, L., Kyriakis, J., Liu, F. F., and Woodgett, J. R. (1996) Curr. Biol. 6, 606-613[Medline] [Order article via Infotrieve]
28. Kim, J. W., Joe, C. O., and Choi, E.-J. (2001) J. Biol. Chem. 276, 27064-27070[Abstract/Free Full Text]
29. Kim, J. W., Chang, T. S., Lee, J. E., Huh, S. H., Yeon, S. W., Yang, W. S., Joe, C. O., Mook-Jung, I., Tanzi, R. E., Kim, T. W., and Choi, E.-J. (2001) J. Cell Biol. 153, 457-463[Abstract/Free Full Text]
30. Park, H. S., Lee, J. S., Huh, S. H., Seo, J. S., and Choi, E.-J. (2001) EMBO J. 20, 446-456[Abstract/Free Full Text]
31. Pap, M., and Cooper, G. M. (1998) J. Biol. Chem. 273, 19929-19932[Abstract/Free Full Text]
32. Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., and Gotoh, Y. (1997) Science 275, 90-94[Abstract/Free Full Text]
33. Klein, P. S., and Melton, D. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 8455-8459[Abstract/Free Full Text]
34. Stambolic, V., Ruel, L., and Woodgett, J. R. (1996) Curr. Biol. 6, 1664-1668[Medline] [Order article via Infotrieve]
35. Zhang, Y., Neo, S. Y., Han, J., and Lin, S. C. (2000) J. Biol. Chem. 275, 25008-25014[Abstract/Free Full Text]
36. Zhang, Y., Neo, S. Y., Wang, X., Han, J., and Lin, S. C. (1999) J. Biol. Chem. 274, 35247-35254[Abstract/Free Full Text]
37. Kohn, A. D., Summers, S. A., Birnbaum, M. J., and Roth, R. A. (1996) J. Biol. Chem. 271, 31372-31378[Abstract/Free Full Text]
38. Alessi, D. R., and Cohen, P. (1998) Genet. Dev. 8, 55-62
39. Burgering, B. M., and Coffer, P. J. (1995) Nature 376, 599-602[CrossRef][Medline] [Order article via Infotrieve]
40. Downward, J. (1998) Curr. Opin. Cell Biol. 10, 262-267[CrossRef][Medline] [Order article via Infotrieve]
41. Hetman, M., Cavanaugh, J. E., Kimelman, D., and Xia, Z. (2000) J. Neurosci. 20, 2567-2574[Abstract/Free Full Text]
42. Cardone, M. H., Salvesen, G. S., Widmann, C., Johnson, G., and Frisch, S. M. (1997) Cell 90, 315-323[Medline] [Order article via Infotrieve]
43. Johnson, N. L., Gardner, A. M., Diener, K. M., Lange-Carter, C. A., Gleavy, J., Jarpe, M B., Minden, A., Karin, M., Zon, L. I., and Johnson, G. L. (1996) J. Biol. Chem. 271, 3229-3237[Abstract/Free Full Text]
44. Baud, V., Liu, Z. G., Bennett, B., Suzuki, N., Xia, Y., and Karin, M. (1999) Genes Dev. 13, 1297-1308[Abstract/Free Full Text]
45. Schlesinger, T. K., Fanger, G. R., Yujiri, T., and Johnson, G. L. (1998) Front. Biosci. 3, 1181-1186
46. Cerezo, A., Martinez-A, C., Lanzarot, D., Fischer, S., Franke, T. F., and Rebollo, A. (1998) Mol. Biol. Cell 9, 3107-3118[Abstract/Free Full Text]
47. Kim, A. H., Khursigara, G., Sun, X., Franke, T. F., and Chao, M. V. (2001) Mol. Cell. Biol. 21, 893-901[Abstract/Free Full Text]
48. Levresse, V., Butterfield, L., Zentrich, E., and Heasley, L. E. (2000) J. Neurosci. Res. 62, 799-808[CrossRef][Medline] [Order article via Infotrieve]
49. Okubo, Y., Blakesley, V. A., Stannard, B., Gutkind, S., and Le Roith, D. (1998) J. Biol. Chem. 273, 25961-25966[Abstract/Free Full Text]
50. Park, H. S., Kim, M. S., Huh, S. H., Park, J., Chung, J., Kang, S. S., and Choi, E.-J. (2002) J. Biol. Chem. 277, 2573-2578[Abstract/Free Full Text]
51. Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M. S., Jin, O., and Woodgett, J. R. (2000) Nature 406, 86-90[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.